1 week ago
SUMMARY
Stocks to watch, NTPC, Bajaj Auto, GR Infraprojects, Brigade Enterprises, Hindustan Zinc, Zydus Lifesciences and more, these are the stocks to watch for tomorrow.
1 / 6
NTPC | State-owned power giant announced plans to issue unsecured, non-convertible debentures (NCDs) worth ₹4,000 crore on March 20, 2025, through a private placement. The NCDs will carry a coupon rate of 7.26% per annum and will mature on March 20, 2040, with a tenure of 15 years. This marks the first issuance under the board resolution dated June 29, 2024, and the subsequent shareholder approval obtained on August 29, 2024. The funds raised will be utilised for capital expenditure, refinancing of existing loans, and other general corporate purposes.
2 / 6
Bajaj Auto | Pune-based automaker said its board of directors has approved the reappointment of Rajivnayan Rahulkumar Bajaj as managing director and chief executive officer for another five-year term, effective April 1, 2025, subject to shareholder approval. Also, Bajaj Auto's board of directors has approved an additional fund infusion of up to ₹1,500 crore into its wholly-owned subsidiary, Bajaj Auto Credit Ltd (BACL).
3 / 6
GR Infraprojects | Infrastructure company said it has received a letter of acceptance (LoA) from the Highways Authority of India (NHAI) for a highway development project worth ₹4,262.78 crore. The contract involves the construction and improvement of the Agra-Gwalior greenfield road across Uttar Pradesh, Rajasthan, and Madhya Pradesh. The project comprises two sections: The development of a six-lane access-controlled highway from Deori in Agra district to Susera in Gwalior district (88.4 km) and the overlay, strengthening, and safety improvements on the existing Agra-Gwalior section of NH-44 (1058 km to 1148 km).
4 / 6
Brigade Enterprises | Real estate company Brigade Group and Gruhas, the investment platform co-founded by Nikhil Kamath and Abhijeet Pai, announced the launch of a dedicated fund for property technology (proptech) and sustainability-driven startups. Earth Fund is said to be India’s first investment fund in this space. The ₹200 crore SEBI-registered Category II Alternative Investment Fund (AIF), with a ₹100 crore green-shoe option, aims to support high-growth startups leveraging technology to solve critical challenges in real estate, construction, and sustainability.
5 / 6
Hindustan Zinc | The Vedanta Group subsidiary has been fined ₹5.42 lakh each by the Bombay Stock Exchange (BSE) and the Stock Exchange (NSE) for non-compliance with board composition norms under Regulation 17(1) of SEBI Listing Regulations. The penalty, imposed on March 17, 2025, was disclosed in a regulatory filing by HZL, which confirmed that the issue stems from a shortfall in the required number of Independent Directors on its board.
6 / 6
Zydus Lifesciences | Drug maker said it has received the final approval from the United States Food and Drug Administration (FDA) to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 mg. Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer. Apalutamide tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad.
